At the conclusion of the Hematology and Medical Oncology Best Practices course, the successful learner will be able to:

Hematology

• understand red cell disorders;
• understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies;
• understand blood and marrow morphology and hematopathology;
• understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors.

Hematologic Malignancies

• be familiar with the diagnosis, evaluation, and management of hematologic malignancies;
• understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs; and
• identify strategies for taking the board examinations.

Oncology

• understand the epidemiology of malignant diseases and management of the medical complications of malignancy;
• recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract;
• understand the principles of management of gynecologic and other genito-urinary malignancies;
• contend with complexity of HIV related malignancies;
• recognize principles of new developments in biologic therapy of cancer.

HEMATOLOGY

• Session 1: Anemias, Bone Marrow Failure, and Sickle Cell Disease
• Session 2: WBC Disorders and Coagulopathy
• Session 3: Thrombocytopenias, Anemias and Myeloproliferative Disease

HEMATOLOGIC MALIGNANCIES

• Session 1: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
• Session 2: AML, Pharmacology, and BMT

MEDICAL ONCOLOGY

• Session 1: Breast Cancer, Lung Cancer, and Neuro-Oncology
• Session 2: GU, GYN and GI Tumors
• Session 3: GI, Sarcoma, and Palliative Care